ALFA FinderNSE filing, NSE: EQUITASBNK. Summary written from the filing by ALFA Finder's alert engine.
Equitas Small Finance Bank Ltd: key numbers
- Share price
- ₹55.96
- Market cap
- ₹6,403 Cr
- Revenue (annual)
- ₹6,794 Cr
- Net profit (annual)
- ₹116.0 Cr
- P/E (TTM)
- 9.1×Sector 20.8×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 15.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Equitas Small Finance Bank Ltd
All →Equitas Small Finance Bank Management Change
Equitas Small Finance Bank's MD & CEO P.N. Vasudevan resigned. Whole-time director Balaji Nuthalapadi was appointed interim MD & CEO for three months.
- Execution
- Three months from November 06, 2026, or until a regular MD & CEO is appointed, whichever is earlier
Equitas Small Finance Bank Capital Structure Change
SBI Mutual Fund sold 2.19 crore Equitas Small Finance Bank shares, cutting its stake from ~5% to 3.07%. The open-market sale reduces the holding to 3.07%.
Equitas Small Finance Bank Earnings Call Transcript: Key Takeaways
Bank crosses ₹1 lakh crore business milestone despite MD P.N. Vasudevan's surprise resignation over family investment conflicts.
Equitas Small Finance Bank Investor Presentation: Key Takeaways
Q2FY27 record PAT Rs218 Cr (vs Rs24 Cr); RoA 1.31%, RoE 13.50%; advances up 30% YoY to Rs50,669 Cr; NIM compressed to 6.69% on surplus liquidity.
Equitas Small Finance Bank Results Update
Equitas Small Finance Bank posted Q2FY27 PAT of ₹218 crore, up 803% YoY. Total business crossed ₹1 lakh crore with advances and deposits each surpassing ₹50,000 crore.
Equitas Small Finance Bank Management Change
Equitas Small Finance Bank's MD & CEO P. N. Vasudevan resigned effective upon successor appointment. The Board will recommend suitable candidates subject to RBI approval.
Other other announcement announcements
All →Neueon Corporation Other Announcement
Neueon Corporation's members approved amendments to its Articles of Association via postal ballot, now approved by the Registrar of Companies. The amendment allows the Board to make multiple calls on partly paid shares.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals filed its RTA report for October 2026 on re-lodgement of physical share transfers. All request counts for the month are NIL.
Leapfrog Engineering Services Other Announcement
Leapfrog Engineering received a Trade Mark registration certificate for building construction services in Class 37. The registration discloses no monetary value or business impact.
Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Vinyas Innovative Technologies Other Announcement
Vinyas Innovative filed CRISIL's monitoring agency report for the quarter ended 30 September 2026. It reports no deviation from objects for its preferential warrant issue proceeds.
Parag Milk Foods Other Announcement
Sixth Sense India Opportunities III sold 43,842 shares on NSE for about Rs 1.45 Crore. Its stake fell from 1.44% to 1.40%.
- Value
- ₹1.45 Cr